Cargando…
Gastrointestinal stromal tumors: a case-only analysis of single nucleotide polymorphisms and somatic mutations
BACKGROUND: Gastrointestinal stromal tumors are rare soft tissue sarcomas that typically develop from mesenchymal cells with acquired gain-in-function mutations in KIT or PDGFRA oncogenes. These somatic mutations have been well-characterized, but little is known about inherited genetic risk factors....
Autores principales: | O’Brien, Katie M, Orlow, Irene, Antonescu, Cristina R, Ballman, Karla, McCall, Linda, DeMatteo, Ronald, Engel, Lawrence S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3827940/ https://www.ncbi.nlm.nih.gov/pubmed/24159917 http://dx.doi.org/10.1186/2045-3329-3-12 |
Ejemplares similares
-
Gastrointestinal Stromal Tumors, Somatic Mutations and Candidate Genetic Risk Variants
por: O'Brien, Katie M., et al.
Publicado: (2013) -
SDHA loss of function mutations in a subset of young adult wild-type gastrointestinal stromal tumors
por: Italiano, Antoine, et al.
Publicado: (2012) -
Risk factors for gastrointestinal stromal tumor recurrence in patients treated with adjuvant imatinib
por: Joensuu, Heikki, et al.
Publicado: (2014) -
Somatic pharmacogenomics of gastrointestinal stromal tumor
por: Ravegnini, Gloria, et al.
Publicado: (2019) -
Imatinib potentiates anti-tumor T cell responses in gastrointestinal stromal tumor through the inhibition of Ido
por: Balachandran, Vinod P., et al.
Publicado: (2011)